Izlaganje sa skupa

Hormonal therapy in systemic lupus erythematosus

Dušanka Martinović Kaliterna ; Odsjek za kliničku imunologiju i reumatologiju, Klinika za unutarnje bolesti, Klinički bolnički centar Split, Split, Hrvatska
Danijela Marasović Krstulović ; Odsjek za kliničku imunologiju i reumatologiju, Klinika za unutarnje bolesti, Klinički bolnički centar Split, Split, Hrvatska
Mislav Radić ; Odsjek za kliničku imunologiju i reumatologiju, Klinika za unutarnje bolesti, Klinički bolnički centar Split, Split, Hrvatska

Sažetak

Estrogens favor the development and/or exacerbation of systemic lupus erythematosus (SLE). Numerous reports have described the association between estrogens exposure (oral contraceptives and menopause hormonal therapy) and development or exacerbation of SLE. Some new studies showed benefit from oral contraceptives and other hormonal therapies without a change in lupus activity but with increased risk of thrombosis. Hormonal therapy in SLE patients should be individual according to clinical presentation and progression of the disease.

Ključne riječi

systemic lupus erythematosus; hormonal therapy; estrogens; menopause

Hrčak ID:

125192

URI

https://hrcak.srce.hr/125192

Datum izdavanja:

21.11.2009.

Podaci na drugim jezicima: hrvatski

Posjeta: 836 *